Targeted Cancer Therapy Research Group

The Targeted Cancer Therapy Group in The Section of Oncology is headed by Professor Hardev Pandha and is based at the Leggett building. The group has access to state of the art laboratories and are conducting cutting edge research into targeted therapies for cancer, diagnostic biomarkers to detect prostate cancer from patient urine and also biomarkers which will aid diagnosis and prognosis of prostate cancer.